Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2026-03-14 @ 10:40 PM
Study NCT ID:
NCT04908735
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2021-05-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant
Sponsor:
Children's Hospital Medical Center, Cincinnati
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2028-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-26
First Submit QC Date:
None
Study First Post Date:
2021-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-16
Last Update Post Date Type:
ESTIMATED